nodes	percent_of_prediction	percent_of_DWPC	metapath
Pergolide—HTR1D—meninx—peripheral nervous system neoplasm	0.0278	0.126	CbGeAlD
Pergolide—HTR1B—dura mater—peripheral nervous system neoplasm	0.0264	0.12	CbGeAlD
Pergolide—HTR1D—dura mater—peripheral nervous system neoplasm	0.0256	0.116	CbGeAlD
Pergolide—HTR2A—phrenic nerve—peripheral nervous system neoplasm	0.0149	0.0678	CbGeAlD
Pergolide—HTR1B—trigeminal nerve—peripheral nervous system neoplasm	0.0114	0.0515	CbGeAlD
Pergolide—HTR1D—trigeminal nerve—peripheral nervous system neoplasm	0.011	0.0499	CbGeAlD
Pergolide—HTR1B—cranial nerve—peripheral nervous system neoplasm	0.00809	0.0367	CbGeAlD
Pergolide—HTR1D—cranial nerve—peripheral nervous system neoplasm	0.00783	0.0356	CbGeAlD
Pergolide—DRD5—ganglion—peripheral nervous system neoplasm	0.00661	0.03	CbGeAlD
Pergolide—HTR2A—trigeminal nerve—peripheral nervous system neoplasm	0.00546	0.0248	CbGeAlD
Pergolide—DRD1—nerve—peripheral nervous system neoplasm	0.00512	0.0232	CbGeAlD
Pergolide—HTR2A—vagus nerve—peripheral nervous system neoplasm	0.00511	0.0232	CbGeAlD
Pergolide—DRD1—ganglion—peripheral nervous system neoplasm	0.00505	0.0229	CbGeAlD
Pergolide—HTR1B—ganglion—peripheral nervous system neoplasm	0.00409	0.0186	CbGeAlD
Pergolide—HTR1D—ganglion—peripheral nervous system neoplasm	0.00396	0.018	CbGeAlD
Pergolide—HTR2C—ganglion—peripheral nervous system neoplasm	0.00392	0.0178	CbGeAlD
Pergolide—HTR2A—cranial nerve—peripheral nervous system neoplasm	0.00389	0.0177	CbGeAlD
Pergolide—HTR2A—pons—peripheral nervous system neoplasm	0.00384	0.0175	CbGeAlD
Pergolide—HTR1A—ganglion—peripheral nervous system neoplasm	0.0033	0.015	CbGeAlD
Pergolide—DRD2—nerve—peripheral nervous system neoplasm	0.00302	0.0137	CbGeAlD
Pergolide—DRD2—ganglion—peripheral nervous system neoplasm	0.00298	0.0136	CbGeAlD
Pergolide—DRD1—brainstem—peripheral nervous system neoplasm	0.0022	0.00997	CbGeAlD
Pergolide—HTR1B—trigeminal ganglion—peripheral nervous system neoplasm	0.00201	0.00913	CbGeAlD
Pergolide—HTR2A—nerve—peripheral nervous system neoplasm	0.00199	0.00905	CbGeAlD
Pergolide—HTR2A—ganglion—peripheral nervous system neoplasm	0.00197	0.00894	CbGeAlD
Pergolide—HTR1D—trigeminal ganglion—peripheral nervous system neoplasm	0.00195	0.00884	CbGeAlD
Pergolide—HTR1B—brainstem—peripheral nervous system neoplasm	0.00178	0.00808	CbGeAlD
Pergolide—HTR1D—brainstem—peripheral nervous system neoplasm	0.00172	0.00782	CbGeAlD
Pergolide—HTR2C—brainstem—peripheral nervous system neoplasm	0.00171	0.00775	CbGeAlD
Pergolide—KCNH2—trigeminal ganglion—peripheral nervous system neoplasm	0.00144	0.00656	CbGeAlD
Pergolide—HTR1A—brainstem—peripheral nervous system neoplasm	0.00144	0.00652	CbGeAlD
Pergolide—ADRA2C—trigeminal ganglion—peripheral nervous system neoplasm	0.00143	0.00647	CbGeAlD
Pergolide—ADRA2C—parotid gland—peripheral nervous system neoplasm	0.00134	0.0061	CbGeAlD
Pergolide—ADRA1A—brainstem—peripheral nervous system neoplasm	0.00132	0.00601	CbGeAlD
Pergolide—DRD2—brainstem—peripheral nervous system neoplasm	0.0013	0.00589	CbGeAlD
Pergolide—ADRA2A—trigeminal ganglion—peripheral nervous system neoplasm	0.00114	0.00516	CbGeAlD
Pergolide—HTR2A—brainstem—peripheral nervous system neoplasm	0.000856	0.00389	CbGeAlD
Pergolide—CYP2D6—brainstem—peripheral nervous system neoplasm	0.00078	0.00354	CbGeAlD
Pergolide—Ergonovine—ABCB1—peripheral nervous system neoplasm	0.000776	1	CrCbGaD
Pergolide—HTR1A—cerebellum—peripheral nervous system neoplasm	0.000708	0.00321	CbGeAlD
Pergolide—ADRA1A—cerebellum—peripheral nervous system neoplasm	0.000653	0.00296	CbGeAlD
Pergolide—DRD2—cerebellum—peripheral nervous system neoplasm	0.00064	0.0029	CbGeAlD
Pergolide—KCNH2—cerebellum—peripheral nervous system neoplasm	0.00063	0.00286	CbGeAlD
Pergolide—ADRA2C—cerebellum—peripheral nervous system neoplasm	0.000622	0.00282	CbGeAlD
Pergolide—ADRA2A—cerebellum—peripheral nervous system neoplasm	0.000496	0.00225	CbGeAlD
Pergolide—HTR2A—cerebellum—peripheral nervous system neoplasm	0.000422	0.00192	CbGeAlD
Pergolide—CYP2D6—cerebellum—peripheral nervous system neoplasm	0.000384	0.00175	CbGeAlD
Pergolide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.00034	CcSEcCtD
Pergolide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000227	0.00034	CcSEcCtD
Pergolide—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000227	0.00034	CcSEcCtD
Pergolide—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000338	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000225	0.000337	CcSEcCtD
Pergolide—Infection—Etoposide—peripheral nervous system neoplasm	0.000225	0.000336	CcSEcCtD
Pergolide—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000336	CcSEcCtD
Pergolide—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000336	CcSEcCtD
Pergolide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000224	0.000336	CcSEcCtD
Pergolide—Nausea—Melphalan—peripheral nervous system neoplasm	0.000224	0.000335	CcSEcCtD
Pergolide—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000334	CcSEcCtD
Pergolide—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000334	CcSEcCtD
Pergolide—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000334	CcSEcCtD
Pergolide—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000222	0.000332	CcSEcCtD
Pergolide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000222	0.000332	CcSEcCtD
Pergolide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000222	0.000331	CcSEcCtD
Pergolide—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000221	0.00033	CcSEcCtD
Pergolide—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00033	CcSEcCtD
Pergolide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000221	0.00033	CcSEcCtD
Pergolide—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000221	0.00033	CcSEcCtD
Pergolide—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00033	CcSEcCtD
Pergolide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00022	0.000329	CcSEcCtD
Pergolide—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000327	CcSEcCtD
Pergolide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000219	0.000327	CcSEcCtD
Pergolide—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000219	0.000327	CcSEcCtD
Pergolide—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000326	CcSEcCtD
Pergolide—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000325	CcSEcCtD
Pergolide—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000325	CcSEcCtD
Pergolide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000216	0.000323	CcSEcCtD
Pergolide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000215	0.000321	CcSEcCtD
Pergolide—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000215	0.000321	CcSEcCtD
Pergolide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.00032	CcSEcCtD
Pergolide—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000211	0.000316	CcSEcCtD
Pergolide—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000316	CcSEcCtD
Pergolide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000211	0.000316	CcSEcCtD
Pergolide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000312	CcSEcCtD
Pergolide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.000311	CcSEcCtD
Pergolide—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000311	CcSEcCtD
Pergolide—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000309	CcSEcCtD
Pergolide—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000309	CcSEcCtD
Pergolide—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000309	CcSEcCtD
Pergolide—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000206	0.000308	CcSEcCtD
Pergolide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000205	0.000307	CcSEcCtD
Pergolide—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000306	CcSEcCtD
Pergolide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000204	0.000304	CcSEcCtD
Pergolide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000203	0.000304	CcSEcCtD
Pergolide—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000203	0.000304	CcSEcCtD
Pergolide—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000303	CcSEcCtD
Pergolide—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000202	0.000302	CcSEcCtD
Pergolide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000202	0.000302	CcSEcCtD
Pergolide—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000301	CcSEcCtD
Pergolide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000201	0.000301	CcSEcCtD
Pergolide—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.000301	CcSEcCtD
Pergolide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0002	0.0003	CcSEcCtD
Pergolide—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000299	CcSEcCtD
Pergolide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000199	0.000297	CcSEcCtD
Pergolide—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000297	CcSEcCtD
Pergolide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.000297	CcSEcCtD
Pergolide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000197	0.000295	CcSEcCtD
Pergolide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000197	0.000294	CcSEcCtD
Pergolide—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000196	0.000292	CcSEcCtD
Pergolide—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000195	0.000292	CcSEcCtD
Pergolide—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000292	CcSEcCtD
Pergolide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000194	0.00029	CcSEcCtD
Pergolide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000194	0.000289	CcSEcCtD
Pergolide—Pain—Etoposide—peripheral nervous system neoplasm	0.000194	0.000289	CcSEcCtD
Pergolide—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000289	CcSEcCtD
Pergolide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000289	CcSEcCtD
Pergolide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000193	0.000289	CcSEcCtD
Pergolide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.000287	CcSEcCtD
Pergolide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000191	0.000286	CcSEcCtD
Pergolide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000285	CcSEcCtD
Pergolide—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000191	0.000285	CcSEcCtD
Pergolide—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.00019	0.000284	CcSEcCtD
Pergolide—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000188	0.000281	CcSEcCtD
Pergolide—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000281	CcSEcCtD
Pergolide—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.000279	CcSEcCtD
Pergolide—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000279	CcSEcCtD
Pergolide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000186	0.000279	CcSEcCtD
Pergolide—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000279	CcSEcCtD
Pergolide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000186	0.000278	CcSEcCtD
Pergolide—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000277	CcSEcCtD
Pergolide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000185	0.000277	CcSEcCtD
Pergolide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000185	0.000276	CcSEcCtD
Pergolide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000184	0.000276	CcSEcCtD
Pergolide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.000273	CcSEcCtD
Pergolide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000183	0.000273	CcSEcCtD
Pergolide—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000182	0.000272	CcSEcCtD
Pergolide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000182	0.000272	CcSEcCtD
Pergolide—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.000271	CcSEcCtD
Pergolide—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.00027	CcSEcCtD
Pergolide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000179	0.000268	CcSEcCtD
Pergolide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000267	CcSEcCtD
Pergolide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000178	0.000266	CcSEcCtD
Pergolide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000177	0.000265	CcSEcCtD
Pergolide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000265	CcSEcCtD
Pergolide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000176	0.000264	CcSEcCtD
Pergolide—Rash—Vincristine—peripheral nervous system neoplasm	0.000176	0.000263	CcSEcCtD
Pergolide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000176	0.000263	CcSEcCtD
Pergolide—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000263	CcSEcCtD
Pergolide—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000175	0.000262	CcSEcCtD
Pergolide—Headache—Vincristine—peripheral nervous system neoplasm	0.000175	0.000262	CcSEcCtD
Pergolide—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.00026	CcSEcCtD
Pergolide—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000258	CcSEcCtD
Pergolide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.000258	CcSEcCtD
Pergolide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000257	CcSEcCtD
Pergolide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000169	0.000253	CcSEcCtD
Pergolide—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000168	0.000252	CcSEcCtD
Pergolide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000167	0.00025	CcSEcCtD
Pergolide—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000166	0.000249	CcSEcCtD
Pergolide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000166	0.000248	CcSEcCtD
Pergolide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000248	CcSEcCtD
Pergolide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000165	0.000247	CcSEcCtD
Pergolide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000245	CcSEcCtD
Pergolide—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000243	CcSEcCtD
Pergolide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000162	0.000243	CcSEcCtD
Pergolide—Chills—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00024	CcSEcCtD
Pergolide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00016	0.000239	CcSEcCtD
Pergolide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000239	CcSEcCtD
Pergolide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000238	CcSEcCtD
Pergolide—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000236	CcSEcCtD
Pergolide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000157	0.000235	CcSEcCtD
Pergolide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000233	CcSEcCtD
Pergolide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000156	0.000233	CcSEcCtD
Pergolide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000155	0.000232	CcSEcCtD
Pergolide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.000231	CcSEcCtD
Pergolide—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000154	0.00023	CcSEcCtD
Pergolide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000229	CcSEcCtD
Pergolide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000228	CcSEcCtD
Pergolide—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000228	CcSEcCtD
Pergolide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000151	0.000226	CcSEcCtD
Pergolide—Back pain—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000225	CcSEcCtD
Pergolide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00015	0.000224	CcSEcCtD
Pergolide—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000222	CcSEcCtD
Pergolide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000221	CcSEcCtD
Pergolide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000219	CcSEcCtD
Pergolide—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000218	CcSEcCtD
Pergolide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000216	CcSEcCtD
Pergolide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000144	0.000215	CcSEcCtD
Pergolide—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000144	0.000215	CcSEcCtD
Pergolide—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000214	CcSEcCtD
Pergolide—Rash—Etoposide—peripheral nervous system neoplasm	0.000143	0.000213	CcSEcCtD
Pergolide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000143	0.000213	CcSEcCtD
Pergolide—Headache—Etoposide—peripheral nervous system neoplasm	0.000142	0.000212	CcSEcCtD
Pergolide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000212	CcSEcCtD
Pergolide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000211	CcSEcCtD
Pergolide—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000211	CcSEcCtD
Pergolide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.00014	0.00021	CcSEcCtD
Pergolide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00014	0.000209	CcSEcCtD
Pergolide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000209	CcSEcCtD
Pergolide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000209	CcSEcCtD
Pergolide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000208	CcSEcCtD
Pergolide—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000208	CcSEcCtD
Pergolide—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000205	CcSEcCtD
Pergolide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000204	CcSEcCtD
Pergolide—Cough—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000203	CcSEcCtD
Pergolide—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000201	CcSEcCtD
Pergolide—Nausea—Etoposide—peripheral nervous system neoplasm	0.000134	0.000201	CcSEcCtD
Pergolide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000134	0.000201	CcSEcCtD
Pergolide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.0002	CcSEcCtD
Pergolide—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000133	0.000199	CcSEcCtD
Pergolide—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000198	CcSEcCtD
Pergolide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000198	CcSEcCtD
Pergolide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000198	CcSEcCtD
Pergolide—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000198	CcSEcCtD
Pergolide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000132	0.000197	CcSEcCtD
Pergolide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000196	CcSEcCtD
Pergolide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000194	CcSEcCtD
Pergolide—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000194	CcSEcCtD
Pergolide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000193	CcSEcCtD
Pergolide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000193	CcSEcCtD
Pergolide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000193	CcSEcCtD
Pergolide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000191	CcSEcCtD
Pergolide—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.00019	CcSEcCtD
Pergolide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00019	CcSEcCtD
Pergolide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000189	CcSEcCtD
Pergolide—Infection—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000189	CcSEcCtD
Pergolide—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000188	CcSEcCtD
Pergolide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000125	0.000187	CcSEcCtD
Pergolide—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000186	CcSEcCtD
Pergolide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000186	CcSEcCtD
Pergolide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000186	CcSEcCtD
Pergolide—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000185	CcSEcCtD
Pergolide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000183	CcSEcCtD
Pergolide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000183	CcSEcCtD
Pergolide—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000183	CcSEcCtD
Pergolide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000183	CcSEcCtD
Pergolide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000183	CcSEcCtD
Pergolide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000181	CcSEcCtD
Pergolide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000181	CcSEcCtD
Pergolide—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000179	CcSEcCtD
Pergolide—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000177	CcSEcCtD
Pergolide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000177	CcSEcCtD
Pergolide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000176	CcSEcCtD
Pergolide—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000174	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000173	CcSEcCtD
Pergolide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000173	CcSEcCtD
Pergolide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000172	CcSEcCtD
Pergolide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000172	CcSEcCtD
Pergolide—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000115	0.000171	CcSEcCtD
Pergolide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.00017	CcSEcCtD
Pergolide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.00017	CcSEcCtD
Pergolide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000169	CcSEcCtD
Pergolide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000169	CcSEcCtD
Pergolide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000167	CcSEcCtD
Pergolide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000167	CcSEcCtD
Pergolide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000165	CcSEcCtD
Pergolide—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000164	CcSEcCtD
Pergolide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000162	CcSEcCtD
Pergolide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000108	0.000162	CcSEcCtD
Pergolide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.00016	CcSEcCtD
Pergolide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000159	CcSEcCtD
Pergolide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000158	CcSEcCtD
Pergolide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000157	CcSEcCtD
Pergolide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000156	CcSEcCtD
Pergolide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000156	CcSEcCtD
Pergolide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000155	CcSEcCtD
Pergolide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000155	CcSEcCtD
Pergolide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000153	CcSEcCtD
Pergolide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00015	CcSEcCtD
Pergolide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.00015	CcSEcCtD
Pergolide—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00015	CcSEcCtD
Pergolide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.0001	0.00015	CcSEcCtD
Pergolide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000145	CcSEcCtD
Pergolide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	9.6e-05	0.000144	CcSEcCtD
Pergolide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000139	CcSEcCtD
Pergolide—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000139	CcSEcCtD
Pergolide—Asthenia—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000136	CcSEcCtD
Pergolide—Pruritus—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000134	CcSEcCtD
Pergolide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.00013	CcSEcCtD
Pergolide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000126	CcSEcCtD
Pergolide—Dizziness—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000125	CcSEcCtD
Pergolide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	8.3e-05	0.000124	CcSEcCtD
Pergolide—Vomiting—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.000121	CcSEcCtD
Pergolide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.00012	CcSEcCtD
Pergolide—Rash—Epirubicin—peripheral nervous system neoplasm	8e-05	0.00012	CcSEcCtD
Pergolide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.99e-05	0.00012	CcSEcCtD
Pergolide—Headache—Epirubicin—peripheral nervous system neoplasm	7.95e-05	0.000119	CcSEcCtD
Pergolide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000116	CcSEcCtD
Pergolide—Nausea—Epirubicin—peripheral nervous system neoplasm	7.54e-05	0.000113	CcSEcCtD
Pergolide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	7.46e-05	0.000112	CcSEcCtD
Pergolide—Rash—Doxorubicin—peripheral nervous system neoplasm	7.4e-05	0.000111	CcSEcCtD
Pergolide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	7.39e-05	0.000111	CcSEcCtD
Pergolide—Headache—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.00011	CcSEcCtD
Pergolide—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.97e-05	0.000104	CcSEcCtD
Pergolide—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.82e-05	0.000256	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.81e-05	0.000255	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.8e-05	0.000253	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.8e-05	0.000253	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.78e-05	0.000252	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	2.75e-05	0.000249	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—TP53—peripheral nervous system neoplasm	2.75e-05	0.000249	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—NRAS—peripheral nervous system neoplasm	2.72e-05	0.000247	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.72e-05	0.000246	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.72e-05	0.000246	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.7e-05	0.000245	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.69e-05	0.000244	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.68e-05	0.000243	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.67e-05	0.000241	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	2.66e-05	0.000241	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.65e-05	0.00024	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	2.65e-05	0.00024	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—GNAS—peripheral nervous system neoplasm	2.64e-05	0.000239	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—HRAS—peripheral nervous system neoplasm	2.63e-05	0.000238	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.62e-05	0.000237	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.61e-05	0.000236	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.6e-05	0.000235	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—ABCB1—peripheral nervous system neoplasm	2.59e-05	0.000235	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.59e-05	0.000235	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.57e-05	0.000233	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—TP53—peripheral nervous system neoplasm	2.57e-05	0.000232	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.57e-05	0.000232	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	2.55e-05	0.000231	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.53e-05	0.000229	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.52e-05	0.000229	CbGpPWpGaD
Pergolide—DRD5—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	2.48e-05	0.000224	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.47e-05	0.000224	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—CASP3—peripheral nervous system neoplasm	2.45e-05	0.000222	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000222	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.45e-05	0.000222	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.43e-05	0.00022	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.41e-05	0.000218	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.41e-05	0.000218	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.38e-05	0.000215	CbGpPWpGaD
Pergolide—ADRA2B—Hemostasis—AKT1—peripheral nervous system neoplasm	2.32e-05	0.00021	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.31e-05	0.000209	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000207	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.28e-05	0.000207	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.27e-05	0.000206	CbGpPWpGaD
Pergolide—DRD5—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	2.25e-05	0.000204	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.24e-05	0.000203	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000203	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.24e-05	0.000203	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—GNAS—peripheral nervous system neoplasm	2.21e-05	0.0002	CbGpPWpGaD
Pergolide—ADRA2C—Hemostasis—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000196	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.14e-05	0.000194	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.11e-05	0.000191	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—TP53—peripheral nervous system neoplasm	2.08e-05	0.000189	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.07e-05	0.000188	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	2.06e-05	0.000187	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—NRAS—peripheral nervous system neoplasm	2.06e-05	0.000186	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2.03e-05	0.000184	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	2.02e-05	0.000183	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	2e-05	0.000181	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—HRAS—peripheral nervous system neoplasm	1.99e-05	0.00018	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.99e-05	0.00018	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.98e-05	0.000179	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.95e-05	0.000177	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.95e-05	0.000177	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.94e-05	0.000176	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.92e-05	0.000174	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.92e-05	0.000173	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.91e-05	0.000173	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.9e-05	0.000172	CbGpPWpGaD
Pergolide—HTR1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.89e-05	0.000172	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.89e-05	0.000171	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.88e-05	0.00017	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.88e-05	0.00017	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.86e-05	0.000169	CbGpPWpGaD
Pergolide—HTR1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.86e-05	0.000168	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.84e-05	0.000167	CbGpPWpGaD
Pergolide—DRD4—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.83e-05	0.000166	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.81e-05	0.000164	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.8e-05	0.000163	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.79e-05	0.000163	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.00016	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.77e-05	0.00016	CbGpPWpGaD
Pergolide—ADRA2A—Hemostasis—AKT1—peripheral nervous system neoplasm	1.76e-05	0.000159	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.75e-05	0.000158	CbGpPWpGaD
Pergolide—HTR2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.74e-05	0.000158	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	1.74e-05	0.000157	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.73e-05	0.000157	CbGpPWpGaD
Pergolide—HTR1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.72e-05	0.000156	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.72e-05	0.000156	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.72e-05	0.000156	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.72e-05	0.000155	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.69e-05	0.000153	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.69e-05	0.000153	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.69e-05	0.000153	CbGpPWpGaD
Pergolide—HTR1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.69e-05	0.000153	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.68e-05	0.000152	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000151	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.67e-05	0.000151	CbGpPWpGaD
Pergolide—DRD4—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.66e-05	0.00015	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.65e-05	0.00015	CbGpPWpGaD
Pergolide—DRD1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.65e-05	0.000149	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.63e-05	0.000148	CbGpPWpGaD
Pergolide—ADRA1D—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000147	CbGpPWpGaD
Pergolide—DRD3—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.62e-05	0.000147	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.61e-05	0.000146	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.61e-05	0.000146	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.6e-05	0.000145	CbGpPWpGaD
Pergolide—HTR2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.58e-05	0.000143	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.58e-05	0.000143	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.57e-05	0.000142	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.56e-05	0.000142	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.54e-05	0.00014	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.54e-05	0.00014	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.54e-05	0.000139	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.54e-05	0.000139	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.52e-05	0.000137	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.51e-05	0.000137	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.5e-05	0.000136	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.49e-05	0.000135	CbGpPWpGaD
Pergolide—DRD1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.49e-05	0.000135	CbGpPWpGaD
Pergolide—DRD3—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA1D—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000134	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.47e-05	0.000133	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.47e-05	0.000133	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000133	CbGpPWpGaD
Pergolide—ADRA2B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.47e-05	0.000133	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.46e-05	0.000132	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.45e-05	0.000132	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.45e-05	0.000131	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.45e-05	0.000131	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.44e-05	0.00013	CbGpPWpGaD
Pergolide—HTR1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.42e-05	0.000128	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.41e-05	0.000128	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.41e-05	0.000128	CbGpPWpGaD
Pergolide—HTR2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000127	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.4e-05	0.000127	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.4e-05	0.000127	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.39e-05	0.000126	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.39e-05	0.000126	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.38e-05	0.000125	CbGpPWpGaD
Pergolide—ADRA2C—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000124	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.37e-05	0.000124	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.36e-05	0.000123	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.36e-05	0.000123	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.35e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000122	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA1B—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.35e-05	0.000122	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.34e-05	0.000121	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.33e-05	0.000121	CbGpPWpGaD
Pergolide—ADRA2B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.33e-05	0.000121	CbGpPWpGaD
Pergolide—DRD5—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.33e-05	0.00012	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.31e-05	0.000118	CbGpPWpGaD
Pergolide—HTR1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000116	CbGpPWpGaD
Pergolide—HTR2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.28e-05	0.000116	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.28e-05	0.000116	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.27e-05	0.000115	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.26e-05	0.000114	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.26e-05	0.000114	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.26e-05	0.000114	CbGpPWpGaD
Pergolide—ADRA2C—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000113	CbGpPWpGaD
Pergolide—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.24e-05	0.000113	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.23e-05	0.000111	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.23e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA1B—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—HTR2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.22e-05	0.000111	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.22e-05	0.00011	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.21e-05	0.00011	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.21e-05	0.00011	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.21e-05	0.000109	CbGpPWpGaD
Pergolide—ADRA1A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.2e-05	0.000108	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.19e-05	0.000107	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.18e-05	0.000107	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.18e-05	0.000106	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.17e-05	0.000106	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.16e-05	0.000105	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.15e-05	0.000104	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.14e-05	0.000104	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.14e-05	0.000103	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.13e-05	0.000103	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.13e-05	0.000102	CbGpPWpGaD
Pergolide—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.13e-05	0.000102	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000102	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.12e-05	0.000101	CbGpPWpGaD
Pergolide—ADRA2A—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000101	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.11e-05	0.000101	CbGpPWpGaD
Pergolide—HTR2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.11e-05	0.000101	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.11e-05	0.0001	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.0001	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.1e-05	9.98e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.09e-05	9.91e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.09e-05	9.86e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.09e-05	9.84e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1.06e-05	9.6e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.06e-05	9.59e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.05e-05	9.47e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—MYC—peripheral nervous system neoplasm	1.04e-05	9.44e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.03e-05	9.34e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	9.34e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—TP53—peripheral nervous system neoplasm	1.03e-05	9.34e-05	CbGpPWpGaD
Pergolide—HTR1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	1.02e-05	9.22e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	1.02e-05	9.19e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.01e-05	9.15e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	1e-05	9.05e-05	CbGpPWpGaD
Pergolide—HTR1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.96e-06	9.02e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.94e-06	9e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.86e-06	8.93e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—HRAS—peripheral nervous system neoplasm	9.86e-06	8.93e-05	CbGpPWpGaD
Pergolide—DRD4—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.81e-06	8.88e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.61e-06	8.7e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.46e-06	8.56e-05	CbGpPWpGaD
Pergolide—HTR2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	9.36e-06	8.48e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—TP53—peripheral nervous system neoplasm	9.31e-06	8.43e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—MYC—peripheral nervous system neoplasm	9.26e-06	8.38e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.24e-06	8.36e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.99e-06	8.14e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.94e-06	8.1e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.91e-06	8.06e-05	CbGpPWpGaD
Pergolide—DRD1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.83e-06	7.99e-05	CbGpPWpGaD
Pergolide—ADRA2C—Metabolism—AKT1—peripheral nervous system neoplasm	8.78e-06	7.95e-05	CbGpPWpGaD
Pergolide—DRD3—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.71e-06	7.89e-05	CbGpPWpGaD
Pergolide—ADRA1D—Signaling Pathways—AKT1—peripheral nervous system neoplasm	8.71e-06	7.89e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.7e-06	7.88e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.6e-06	7.79e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.6e-06	7.78e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—TP53—peripheral nervous system neoplasm	8.56e-06	7.75e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.55e-06	7.74e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.32e-06	7.53e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—HRAS—peripheral nervous system neoplasm	8.19e-06	7.41e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.89e-06	7.15e-05	CbGpPWpGaD
Pergolide—ADRA2B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.86e-06	7.12e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.77e-06	7.03e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.6e-06	6.89e-05	CbGpPWpGaD
Pergolide—HTR1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.59e-06	6.87e-05	CbGpPWpGaD
Pergolide—HTR2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.55e-06	6.84e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.55e-06	6.84e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.43e-06	6.73e-05	CbGpPWpGaD
Pergolide—ADRA2C—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.35e-06	6.65e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	7.27e-06	6.59e-05	CbGpPWpGaD
Pergolide—ADRA1B—Signaling Pathways—AKT1—peripheral nervous system neoplasm	7.23e-06	6.55e-05	CbGpPWpGaD
Pergolide—ADRA2A—Metabolism—AKT1—peripheral nervous system neoplasm	7.14e-06	6.46e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.07e-06	6.4e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.76e-06	6.12e-05	CbGpPWpGaD
Pergolide—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.66e-06	6.04e-05	CbGpPWpGaD
Pergolide—HTR2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.56e-06	5.94e-05	CbGpPWpGaD
Pergolide—ADRA1A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.42e-06	5.81e-05	CbGpPWpGaD
Pergolide—ADRA2A—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.97e-06	5.4e-05	CbGpPWpGaD
Pergolide—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	4.65e-06	4.21e-05	CbGpPWpGaD
Pergolide—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.04e-06	2.75e-05	CbGpPWpGaD
